SECURITIES
AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549

Form
10-QSB

Quarterly
Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934

For Quarter
Ended:     November 30, 2005

Mammatech
Corporation(Exact name of registrant as specified in its charter)

|                                        |  |                      
|--------------------------------------- |  | ---------------------
|Florida                                 |  | 0-11050              
|(State or
      other jurisdiction      |  | (Commission File No.)
|of
      incorporation or organization) |  |                      

|                                          | 
|----------------------------------------- | 
|
|930 N.W. 8th Avenue, Gainesville, Florida | 
|(Address of principal executive offices)  | 

(352)
375-0607(Registrant's telephone number, including area code)

Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by section 13 or 15 (d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past ninety days. Yes [ X ] No [   ]

Indicate
by a check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act)Yes [   ] No [ X ]

Indicate
the number of shares outstanding of each of the issuers classes of common
stock, as of the latest practicable date:

Number of
shares outstanding on Nov. 30, 20055,227,625
shares of which310,425 are treasury shares

TITLE OF EACH
CLASS

Common stock
$.0001 par value

Transitional
Small Business Disclosure Format Yes [   ]  No [ X ]

The total
number of pages of this report is 14

---

Mammatech
Corporation

INDEX

|                                                                                                | 
|----------------------------------------------------------------------------------------------- | 
|PART I                                                                                          | 
|FINANCIAL INFORMATION                                                                           | 
|Item 1.  Financial Statements                                                                   | 
|Balance Sheets for November 30, 2005                                                            | 
|Statements of Operations for Three Months Ended Nov. 30, 2005 and Nov. 30, 2004                 | 
|Statement of Cash Flow for the Three Months Ended Nov. 30, 2005 and Nov. 30, 2004               | 
|Notes to Financial Statements                                                                   | 
|Item 2.  Management's Discussion and Analysis of Financial Conditions and Results of Operations | 
|Item 3.  Controls and Procedures                                                                | 
|PART II  OTHER INFORMATION                                                                      | 
|Item 6.  Exhibits and Reports on Form 8-K                                                       | 
|SIGNATURES                                                                                      | 
|EXHIBITS                                                                                        | 

2

---

Mammatech
CorporationBalance SheetNovember 30, 2005(Unaudited)

ASSETS

|                                                 | 
|------------------------------------------------ | 
|Current assets:                                  | 
|Cash                                             | 
|Accounts receivable - trade                      | 
|Inventory                                        | 
|                                                 | 
|Total current assets                             | 
|                                                 | 
|Property and equipment, at cost, net             | 
|                                                 | 
|Available for sale securities                    | 
|Patents, trademarks and other intangibles, net   | 
|                                                 | 
|                                                 | 
|                                                 | 
|                                                 | 
|                                                 | 
|LIABILITIES AND STOCKHOLDERS' EQUITY             | 
|Current liabilities:                             | 
|Note payable                                     | 
|Accounts payable and accrued expenses            | 
|Accounts payable and accrued salaries - officers | 
|                                                 | 
|Total current liabilities                        | 
|                                                 | 
|Stockholders' equity:                            | 
|Common stock, $.0001 par value,                  | 
|200,000,000 shares authorized, 5,227,625         | 
|shares issued and outstanding                    | 
|Additional paid-in capital                       | 
|Accumulated (deficit)                            | 
|                                                 | 
|                                                 | 
|Treasury stock, at cost, 310,425 shares          | 
|                                                 | 
|                                                 | 
|Other comprehensive income:                      | 
|Valuation allowance for marketable securities    | 
|                                                 | 
|                                                 | 
|                                                 | 
|                                                 | 
|                                                 | 

See
accompanying notes to financial statements.

3

---



Mammatech
CorporationStatements of Comprehensive OperationsThree Months Ended November 30,
(Unaudited)

|                                               | 2005 | 2004                     
|---------------------------------------------- | ---- | -------------------------
|
|Sales, net                                     |      | $                  82,100
|Cost of sales                                  |      | 20,610                   
|                                               |      |                          
|Gross profit                                   |      | 61,490                   
|                                               |      |                          
|Selling, general and administrative expenses   |      | 93,193                   
|                                               |      |                          
|(Loss) from operations                         |      | (31,703                  
|                                               |      |                          
|Other income and (expense):                    |     
|Gain (loss) on sale of investment securities   |      | --                       
|Interest and dividend income                   |      | 6,317                    
|                                               |      |                          
|                                               |      | 6,317                    
|                                               |      |                          
|(Loss) before income taxes                     |      | (25,386                  
|Provision for income taxes                     |      | --                       
|                                               |      |                          
|Net (loss)                                     |      | $               (25,386  
|                                               |      |                          
|Basic and fully diluted earnings per share:    |     
|Net income  (loss)                             |      | $                   (0.00
|                                               |      |                          
|Weighted average shares outstanding            |      | 5,227,625                
|                                               |      |                          
|Net (loss)                                     |      | $               (25,386  
|Unrealized gain (loss) from investments net of |     
|income taxes                                   |      | (7,639                   
|                                               |      |                          
|Comprehensive (loss)                           |      | $               (33,025  
|                                               |      |                          

See
accompanying notes to financial statements.

4

---



Mammatech
CorporationStatements of Cash FlowsThree Months Ended November 30,(Unaudited)

|                                                        | 2005 | 2004          
|------------------------------------------------------- | ---- | --------------
|
|Cash flows from operating activities:                   |      |               
|Net cash provided by (used in) operating activities     |      | $      (21,135
|                                                        |      |               
|Cash flows from investing activities:                   |     
|Purchase of available for sale securities               |      | --            
|Proceeds from the sale of available for sale securities |      | --            
|Acquisition of property and equipment                   |      | (1,123        
|                                                        |      |               
|Net cash provided by (used in) investing activities     |      | (1,123        
|                                                        |      |               
|Cash flows from financing activities:                   |     
|Repayment of note payable                               |      | --            
|                                                        |      |               
|Net cash (used in) financing activities                 |      | --            
|                                                        |      |               
|(Decrease) in cash and cash equivalents                 |      | (22,258       
|Cash and cash equivalents,                              |     
|beginning of period                                     |      | 79,758        
|                                                        |      |               
|Cash and cash equivalents,                              |     
|end of period                                           |      | $      57,500 
|                                                        |      |               

See
accompanying notes to financial statements.

5

---

MAMMATECH
CORPORATIONNOTES TO FINANCIAL STATEMENTSNOVEMBER 30, 2005(UNAUDITED)

(1)      Basis Of Presentation

The
accompanying unaudited financial statements have been prepared in accordance
with generally accepted accounting principles (GAAP) for interim financial
information and Item 310(b) of Regulation S-B. They do not include all of the
information and footnotes required by GAAP for complete financial statements. In
the opinion of management, all adjustments (consisting only of normal recurring
adjustments) considered necessary for a fair presentation have been included.

The
results of operations for the periods presented are not necessarily indicative
of the results to be expected for the full year. For further information, refer
to the financial statements of the Company as of August 31, 2005, and for the
two years then ended, including notes thereto included in the Companys
Form 10-KSB.

(2)     Earnings
Per Share

The
Company calculates net income (loss) per share as required by Statement of
Financial Accounting Standards (SFAS) 128, Earnings per Share. Basic
earnings (loss) per share is calculated by dividing net income (loss) by the
weighted average number of common shares outstanding for the period. Diluted
earnings (loss) per share is calculated by dividing net income (loss) by the
weighted average number of common shares and dilutive common stock equivalents
outstanding. During periods when anti-dilutive commons stock equivalents are not
considered in the computation.

(3)     Inventory

Inventory
is stated at the lower of cost, determined on a first in, first out basis, or
market value. Inventory consists principally of finished goods and packaging
materials.

(4)     
Available For Sale Securities

Marketable
securities consist of the following at November 30, 2005:

Mutual
funds and equity securities with a fair market value of $564,036. The cost basis
of these securities is $574,106.

The
gross realized gains (losses) on sales of available-for-sale securities were $0
during the three months ended November 30, 2005. The unrealized holding (losses)
on available-for-sale securities included in accumulated other comprehensive
income as a component of stockholders equity increased by $(7,639) during
the three months ended November 30, 2005, and totaled $(10,070) at November 30,
2005.

During
the three months ended November 30, 2005, the Company increased its investment
in available for sale securities by $0 and realized net proceeds from the sale
of available for sale securities of $0.

6

---

MANAGEMENT'S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATION FOR MAMMATECH
CORPORATION

| | The following
discussion should be read in conjunction with the accompanying  financial statements and
notes thereto included within this Quarterly Report on  Form 10-QSB. In addition to
historical information, the information in this  discussion contains forward-looking
statements within the meaning of Section 27A  of the Securities Act of 1933, as amended,
and Section 21E of the Securities  Exchange Act of 1934, as amended. These
forward-looking statements involve risks  and uncertainties, including statements
regarding the Companys capital  needs, business strategy and expectations. Any
statements contained herein that  are not statements of historical facts may be deemed to
be forward-looking  statements. In some cases, you can identify forward-looking
statements by  terminology such as may, will, should,
expect, plan, Intend,  anticipate, believe,
estimate,  predict, potential or continue, the
negative  of such terms or other comparable terminology. Actual events or results may
differ materially. In evaluating these statements, you should consider various  factors
described in this Quarterly Report, including the risk factors  accompanying this
Quarterly Report, and, from time to time, in other reports the  Company files with the
Securities and Exchange Commission. These factors may  cause the Companys actual
results to differ materially from any  forward-looking statement. The Company disclaims
any obligation to publicly  update these statements, or disclose any difference between
its actual results  and those reflected in these statements. The information constitutes
forward-looking statements within the meaning of the Private Securities  Litigation
Reform Act of 1995.
| | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

OVERVIEW

| | Results for
the first quarter of Fiscal 2006 were mixed. Sales decreased by 4% over the  previous
quarter but increased by 11% compared to the first quarter of 2005.  Operating costs of
$93,193 represent a 16.4% decrease relative to the prior year  quarter. The net loss of
$25,386 is 46% less than the corresponding figure from  a year ago.
| | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | The Company
trained 5 additional MammaCare Specialists during the quarter. Four of  these were
trained at the Oregon Health Sciences University facility.  Coordinated marketing
approaches are now being pursued emphasizing the  geographical variety in training sites.
The Company continues to pursue its  strategy of establishing additional training sites
both in the United States and  abroad. Presently, the Company is in discussion with a
prominent health care  provider in the Midwest. There can be no assurance that these
discussions will  result in a new national site or that, if concluded, significant
revenues will  result.
| | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

7

---

| | During the
quarter, eleven MammaCare BSE instructors were trained and certified in  Germany and 5
MammaCare Clinical Breast Examiners were trained and certified in  New Mexico.
| | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | A major
research project involving MammaCare BSE training was completed in Taiwan  during the
quarter. Preliminary analysis of the results indicates that Taiwanese  women learn and
retain the MammaCare method of BSE at a proficiency level  comparable to that of
published data for United States women.
| | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | The Company
continues to expend resources to complete development of its patented  tactile computer
technology tentatively termed the Palpation Assessment Device  (PAD). The PAD is the
first computer-based system that teaches and evaluates  manual breast examination skills.
Currently, the PAD is undergoing testing as  part of Specialist training.
| | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | With the
exception of a small note to an unaffiliated supplier for a manufacturing  facility, the
Company remains debt free and has no immediate liquidity problems.  The Company continues
to seek an affiliation with a larger partner in the  healthcare industry.
| | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Item 3.  Controls and Procedures

| | As
of the end of the period covered by this report, the Corporations Chief Executive
Officer and Chief Financial Officer evaluated the effectiveness of the Corporations
disclosure controls and procedures. Based on the evaluation, the Corporations Chief
Executive Officer and Chief Financial Officer concluded that the Corporations
disclosure controls and procedures are effective as of the end of the period covered by
this report in that information required to be disclosed in reports filed under the
Securities Exchange Act of 1934, as amended, has been recorded, processed, summarized and
reported within the current fiscal quarter. There were no changes in the Corporations
internal control over financial reporting that occurred during the Corporatioins
most recent fiscal quarter that have materially affected, or are reasonably likely to
materially affect, the Corporations internal control over financial reporting.
| | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

PART II - OTHER
INFORMATION

Item 1.     Legal
Proceedings

None

Item 2.     Changes
in securities

None

Item  3.      Default
upon senior securities

None

8

---

Item  4.     Submissions
of matters to a vote of securities holders

None

Item  5.      Other
information

None

Item 6.      Exhibits and
Reports on Form 8-K

None

9

---

10-QSB

For the three
months ended Nov. 30, 2005

Signatures

Pursuant  to
the requirements of the Securities Exchange Act of 1934, the registrant has  duly caused
this report to be signed on its behalf by the undersigned thereunto  duly authorized.

DATE:

| | MAMMATECH
CORPORATION
| | ---------------------

| | BY:     /s/      Henry S. PennypackerPresident and Director
| | -----------------------------------------------------------

| | BY:     /s/      Mary SellersTreasurer and Chief Financial Officer
| | ------------------------------------------------------------------

10